hypertriglyceridemia
Conditions
Interventions
Control group:Jieyu Qutan Huazhuo prescription placebo
Experimental group:Jieyu Qutan Huazhuo prescription
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Aged between 18 and 80; (2) Meet the diagnostic criteria of hypertriglyceridemia; (3) Meet the diagnostic criteria of qi stagnation and phlegm obstruction syndrome; (4) Those who are using other lipid-lowering drugs or therapies (including physical therapy) should stop taking the drugs or stop the therapy and still meet the above standards after 2 weeks of elution; (5) Voluntarily join the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Secondary hypertriglyceridemia caused by hypothyroidism, nephrotic syndrome, diabetes and other diseases; (2) Have suffered from acute cardiovascular and cerebrovascular events or severe trauma within 1 year; (3) Patients who need to take drugs with definite influence on triglyceride level for a long time after previous PCI or other major surgery; (4) Patients suffering from systemic serious diseases of the heart, brain, liver, kidney and immune system, or mental patients; (5) The patient is using drugs that affect lipid metabolism, such as glucocorticoids, thyroid hormones, and moderate potency diuretics (6) The patient or his/her spouse is in the stage of pregnancy, pregnancy or lactation; (7) People who may be allergic to the drug in this test; (8) Other circumstances that may affect the efficacy and safety of the test drug.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score; | — |
Primary
| Measure | Time frame |
|---|---|
| Triglyceride levels; | — |
Countries
China
Contacts
Public ContactKuiwu Yao
Outcome results
None listed